Indications |
Oral Severe anaerobic infections Adult: 150-300 mg every 6 hr. May increase to 450 mg every 6 hr in more severe infections. Max: 1.8 g/day. Child: 3-6 mg/kg every 6 hr. Children weighing <10 kg should receive at least 37.5 mg every 8 hr. Renal impairment: Severe: dosage adjustment may be needed. Hepatic impairment: Severe: dosage adjustment may be needed. Oral Prophylaxis of endocarditis Adult: 600 mg 1 hr before dental procedure. 300 mg may be given via IV inj (over at least 10 minutes) for high-risk patients undergoing dental procedures involving general anaesthesia. Renal impairment: Severe: dosage adjustment may be needed. Hepatic impairment: Severe: dosage adjustment may be needed. Intravenous Severe anaerobic infections Adult: 0.6-2.7 g daily in divided doses, increased to 4.8 g daily in very severe infections. Child: >1 mth: 15-40 mg/kg daily in divided doses. A min dose of 300 mg daily should be given regardless of body weight. Renal impairment: Severe: dosage adjustment may be needed. Hepatic impairment: Severe: dosage adjustment may be needed. Intravenous Toxic shock syndrome Adult: 900 mg every 8 hr, in combination with penicillin G or ceftriaxone. Hepatic impairment: Severe: dosage adjustment may be needed. Intravenous Pelvic inflammatory disease Adult: 900 mg every 8 hr. To be used with gentamicin. Hepatic impairment: Severe: dosage adjustment may be needed. Topical/Cutaneous Acne Adult: As 1% preparation: Apply a thin layer onto affected area bid. Renal impairment: Severe: dosage adjustment may be needed. Vaginal Bacterial vaginosis Adult: As pessary or 2% cream: 100 mg once nightly for 3-7 days. Renal impairment: Severe: dosage adjustment may be needed. Hepatic impairment: Severe: dosage adjustment may be needed. |
Contraindications |
Hypersensitivity. |
Warnings / Precautions |
Renal and hepatic diseases; pregnancy and lactation; GI disease; elderly, females, neonates, atopic patients. Regular monitoring of blood counts, liver and kidney functions. |
Adverse Reactions |
Diarrhoea, nausea, vomiting, abdominal pain; erythema multiforme, contact dermatitis, exfoliative and vesiculous dermatitis, urticaria; eosinophilia; local irritation, thrombophloebitis. Potentially Fatal: Gasping syndrome (neonates); pseudomembranous colitis. |
Overdose Reactions |
Dialysis or peritoneal dialysis unlikely to be helpful. |
Drug Interactions |
Antagonises effects of parasympathetics. Potentially Fatal: Respiratory depression with neuromuscular blockers. See Below for More clindamycin Drug Interactions |
Food Interactions |
May reduce rate of absorption. |
Mechanism of Actions |
Clindamycin inhibits protein synthesis by reversibly binding to the 50S subunit of the ribosomal thus blocking the transpeptidation or translocation reactions of susceptible organisms resulting to stunted cell growth. Absorption: 90% absorbed from the GI tract (oral), absorbed from the skin (topical), systemically (intravaginal); rate of absorption may be reduced by the presence of food. Distribution: Body tissues and fluids (wide), bone, bile (high concentrations), leukocytes, macrophages; crosses the placenta and enters breast milk. Protein-binding: >90% Metabolism: Hepatic; converted to N-demethyl and sulfoxide metabolites and some inactive metabolites. Excretion: Via urine (10% as active drug or metabolites), via faeces (4% as inactive metabolites); 2-3 hr (elimination half-life), may be prolonged in preterm neonates and severe renal impairment. |
Administration |
Granules: Should be taken with food. Cap: May be taken with or without food. (Swallow whole w/ a full glass of water & in an upright position.) |
Storage Conditions |
Intravenous: Store at 20-25°C. Oral: Store at 20-25°C. Topical/Cutaneous: Store at 20-25°C. Vaginal: Store at 20-25°C. |
ATC Classification |
D10AF01 - clindamycin ; Belongs to the class of topical antiinfective preparations used in the treatment of acne. G01AA10 - clindamycin ; Belongs to the class of antibiotics. Used in the treatment of gynecological infections. J01FF01 - clindamycin ; Belongs to the class of lincosamides. Used in the systemic treatment of infections. |
Storage |
Intravenous: Store at 20-25°C. Oral: Store at 20-25°C. Topical/Cutaneous: Store at 20-25°C. Vaginal: Store at 20-25°C. |
Available As |
|
Clindamycin
Post Review about Clindamycin Click here to cancel reply.
Clindamycin Containing Brands
Clindamycin is used in following diseases
Drug - Drug Interactions of Clindamycin
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.